VAERS reports by lot

GSK DTaP/Tdap lot PP9L5: VAERS reports

38 VAERS reports list lot PP9L5 as a GSK DTaP/Tdap vaccine, received between 2019-08-19 and 2024-10-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
0%
Marked serious
0
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3970%
Allergic / Anaphylactic47%
Neurological35%
Dermatological (non-injection-site)35%
General / Systemic (non-local)35%
Gastrointestinal24%
Cardiac / Cardiovascular12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan8
Washington6
Texas4
Iowa2
Missouri2
Florida2
Louisiana1
California1
Utah1
Massachusetts1
Maryland1
Puerto Rico1

Reports by month received

2019-081
2019-101
2019-122
2020-012
2020-021
2020-051
2020-068
2020-073
2020-081
2020-093
2020-101
2020-112
2021-012
2021-031
2021-051
2021-061
2021-071
2021-091
2021-103
2021-111
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.